Fundraising FoxEFung Capital
Venture capitalShenzhen · Series A–Growth
Find your way into EFung Capital
Sign up to see every warm intro you have to EFung Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EFung Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
EFung Capital concentrates on global biopharmaceutical and biomedical VC/PE investing, aiming to use capital to drive the industrialization of biotech innovations. Its investment team is composed of biomedical PhDs from top domestic and international universities, giving it deep specialist expertise. The firm leverages abundant industry resources and quality deal flow across both China and the US, and structures investment strategies around companies' core needs. It operates a systematic 'five-in-one' model integrating investment, financing, risk control, management, and service, and provides customized post-investment support to enhance portfolio company value. EFung has backed numerous companies that later completed IPOs.
Source: firm website, verified Sep 27, 2026.
What they invest in
from 29 of 76 portfolio companiesHealthtech ×22Biotech ×21Medical Devices ×13Hardware ×3Digital Health ×2Advanced Manufacturing ×1AI & Machine Learning ×1Deep Tech ×1
HQs:China×13United States×5
Who they back
founder profiles across 8 portfolio companiesFounding team size:solo founder×62 founders×2
Investments · 76 tracked
founders shown can be your intro pathACM Biolabs develops a patent-protected polymer/lipid hybrid, non-viral drug delivery technology (ATP) that carries payloads such as oligonucleotides, small molecules, proteins, and mRNA to improve their efficacy.
BiotechHealthtech
Madhavan Nallani(Founder)
Aleva Neurotherapeutics develops a high-resolution neurostimulation platform that delivers targeted therapy with high selectivity.
HealthtechMedical Devices
Co-investorsKinled Holding
BiotechSan Carlos, US
Xiaodong Yang(President, CEO and Secretary)inOvid Trifan(Executive Officer)Amy Wong(Executive Officer)Francis Sarena(Chief Operating Officer)Frank Hsu(Chief Medical Officer)William Duke, Jr.(Chief Financial Officer)
Co-investorsShangBay Capital LLCSVE Capital3E Bioventures CapitalDecheng CapitalSv Tech Ventures, Inc.Virtus Inspire Ventures
Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer.
BiotechFemTechMedical Devices
Kevin Pan(Founder)
Co-investorsQiming Venture PartnersTriWise CapitalYF Capital
Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types.
BiotechHealthtechMedical Devices
Co-investorsDecheng CapitalSangel Capital
Centrexion develops therapies for the treatment of pain, focusing on the design and execution of clinical trials for pain drug development.
BiotechHealthtechBaltimore, US
James N. Campbell(President, Chief Scientific Officer)inKerrie L. Brady(Executive Officer)inGregg Beloff(Executive Officer)Jeffrey B. Kindler(Chief Executive Officer)inCharles Oh(Chief Medical Officer)inSmital Shah(Acting CBO)in
Co-investorsCatalio Capital Management, LPNew Enterprise Associates (NEA)Quan Capital6 Dimensions CapitalAvoro Capital AdvisorsExome Asset Management
Xian-ping LU(Founder)in
Co-investorsLAVLilly Asia VenturesLYZZ CapitalVertex Ventures China
Elicio Therapeutics is a biopharmaceutical company focused on developing therapeutic treatments.
BiotechHealthtech
Co-investorsClal Biotechnology Industries
HaploX (海普洛斯) develops gene sequencing, liquid biopsy, and genomic big-data technologies for cancer detection and genetic screening.
AI & Machine LearningBiotechDigital HealthShenzhen, CN
Chen Shifu(Founder)in
Biopharma company (和铂医药), HK-listed (02142.HK).
Jingsong Wang(Founder)in
Co-investorsVertex Ventures ChinaLegend Capital
Insight-Med is a medtech company developing interventional cardiovascular devices, including a domestic fractional flow reserve (FFR) system approved by China's NMPA and an intravascular ultrasound (IVUS) system for precision diagnosis and treatment of cardiovascular diseases.
HealthtechMedical DevicesShenzhen, CN
Co-investorsDecheng CapitalHongShan Capital GroupQiming Venture Partners
Lifotronic is a Chinese medical diagnostics and healthcare company that develops in vitro diagnostic products, clinical medical devices, dermatology and aesthetic solutions, and consumer health offerings.
Digital HealthHealthtechMedical DevicesShenzhen, CN
Co-investorsGreen Pine Capital Partners
LumiThera develops the Valeda Light Delivery System, an FDA-authorized photobiomodulation (PBM) device that applies multiple light wavelengths to treat early and intermediate dry age-related macular degeneration (AMD).
BiotechHealthtechMedical DevicesPoulsbo, US
Tracy Puckett(Executive Officer)Clark Tedford(Executive Officer, Director)inScott Bradley(Executive Officer)inDuane Morrison(Executive Officer)inCindy Croissant(Executive Officer)Ryan Montecucco(Executive Officer)
Co-investors3E Bioventures CapitalKeiretsu ForumLife Sciences Greenhouse InvestmentsImagine VenturesKeiretsu Capital
HealthtechGolden Valley, US
Steve Anderson(Executive Officer, Director)inJoe Delgado(Executive Officer)inJohn Seaberg(Executive Officer, Director)inToni Baraga(Executive Officer)
BoardFeng Jiang(Director)Buzz Benson(Director)
Co-investorsHeuristic Capital Partners
Tactiva Therapeutics develops immuno-oncology treatments using adoptive cell therapy approaches for cancer patients.
BiotechHealthtechMedical DevicesChicago, US
Richard C. Koya(Co-Founder)Kunle Odunsi(Co-Founder)Jay Zhang(CEO)
Co-investorsPanacea VentureVI Partners
Weimai (唯迈) develops medical imaging systems and clinical solutions for interventional procedures, including cardiovascular, neurointerventional, gastrointestinal, obstetric/gynecological (low-dose), and orthopedic imaging.
HardwareHealthtechMedical Devices
Co-investorsMarathon Venture Partners
KBP Biosciences is a biotechnology research and development organization that discovers and develops innovative therapeutic drugs for unmet medical needs using an integrated discovery and development platform.
Biotech
Co-investorsSangel Capital
Guangdong Raynovent Biotech is a biotech company focused on discovering, developing, and commercializing innovative drugs for respiratory and metabolic diseases.
BiotechHealthtechGuangzhou, CN
Quaero Life (Jiaxing Kaishi Biotechnology) develops, manufactures, and services in vitro diagnostic (IVD) instruments and life science consumables, providing automated and intelligent solutions for the IVD industry.
Advanced ManufacturingBiotechMedical DevicesJiaxing, CN
Co-investorsShanghai Creation Investment
Hubei Topgene Biotechnology is a CRO founded in 2009 that specializes in large-animal studies and focuses on preclinical drug research and evaluation, offering nonclinical safety, pharmacodynamics, pharmacokinetics, bioanalysis, molecular imaging, medical device evaluation, and non-human primate breeding services.
BiotechHealthtechMedical DevicesWuhan, CN
TG ImmunoPharma is a biotech company focused on NK (natural killer) cell-based therapeutics.
Biotech
Pharma technology company founded in 2010 focused on precision oncology medicine.
Co-investorsCo-Win VenturesSangel Capital
Atom Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule therapies for chronic gout, acute gout, and hyperuricemia.
BiotechHealthtech
Jingze (Jingze Biopharmaceutical) is a Chinese biopharmaceutical company developing drug candidates focused on assisted reproduction and ophthalmology.
BiotechHealthtechChengdu, CN
Shenzhen CoreTech Medical develops and manufactures artificial hearts and mechanical circulatory support devices for patients with advanced refractory heart failure.
HardwareHealthtechMedical DevicesShenzhen, CN
Resverlogix is a late-stage clinical biotechnology company developing epigenetic therapeutics for patients with chronic illnesses and high unmet medical need.
BiotechHealthtech
Donald McCaffreyNorman Wong
Wuhan Oryzogen is a biopharmaceutical company that develops plant-based recombinant protein expression technology and products, having built an industrialization and quality-assurance system for plant-derived biologic drugs in China.
BiotechHealthtechWuhan, CN
Suzhou Meichuang Medical Technology develops, manufactures, and commercializes high-end medical devices focused on peripheral vascular intervention, tumor/oncology intervention, and hemodialysis access.
HardwareHealthtechMedical DevicesSuzhou, CN
Westlake Omics develops FAXP spatial proteomics technology, which uses tissue volume expansion to improve the quantity and quality of protein identifications while reducing analysis time.
BiotechDeep TechHealthtech
Shenzhen Jifu Medical Technology develops magnetically controlled capsule endoscopy systems for gastrointestinal examination, used in hospital digestive/gastroenterology settings.
HealthtechMedical DevicesShenzhen, CN
Highlight Pharma (高光制药) is a clinical-stage biopharmaceutical company developing novel drugs for autoimmune and inflammatory diseases of the peripheral and central nervous systems.
BiotechHealthtech
Gmax Biopharm develops therapeutic monoclonal antibodies targeting G protein-coupled receptors (GPCRs), using proprietary antibody discovery platforms.
Biotech
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ARDISnurtronTriArm上海和元中逸安科亚盛医药凌意生物前沿生物北芯生命医诺智能华昊中天华源再生医学和元生物和美药业图微安创宽岳骨科思路迪医药恩沐生物拨康视云捷思英达晟斯生物普罗吉医药标新生物汉诺医疗泰诺麦博济因生物烛照生物环码生物瑞一科技瑞斯普利瑞莱生物百傲科技盛禾生物真实生物科睿驰纯钧新材料纽龙生物美中双和英美达荃信生物金阳烯碳新材料铂鑫生物长泰药业驯鹿生物
Portfolio news
latest coverage across their companies
Centrexion Therapeutics · trysignalbase.com · Mar 25, 2026
Frequently asked questions
- How many investments has EFung Capital made?
- EFung Capital has 76 tracked investments.
- What stage does EFung Capital invest at?
- EFung Capital invests at the Series A, Series B, Series C, Growth stages.
- What sectors does EFung Capital focus on?
- EFung Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is EFung Capital located?
- EFung Capital is headquartered in Shenzhen, CN.
- Who does EFung Capital co-invest with?
- EFung Capital most often shares deals with Sangel Capital, Decheng Capital, Qiming Venture Partners, among 24 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.